Skip to main content
. 2021 Sep 20;71(8):1567–1576. doi: 10.1136/gutjnl-2021-325181

Figure 3.

Figure 3

Evaluation of secondary study endpoints after screening and at 2, 6 and 12 months according to IBS type. (A) Number of days with flatulence/bloating per week, (B) median stool type (according to Bristol Stool Scale), (C) number of days without pain per week, (D) number of bowel movements per day, (E) number of days with bowel movements per week, (F) number of days with stool type 6 or 7 (according to Bristol Stool Scale), (G) number of days with urge of bowel movement per week. (H) IBS-SSS. IBS-SSS, irritable bowel syndrome-Symptom Severity Scale.